| Dokumendiregister | Ravimiamet |
| Viit | REP-1/1198-1 |
| Registreeritud | 05.03.2025 |
| Sünkroonitud | 06.03.2025 |
| Liik | Sissetulev kiri |
| Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
| Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
| Toimik | REP-1/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | European Directorate for the Quality of Medicines & HealthCare |
| Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
| Vastutaja | Signe Leito (RA, Peadirektori asetäitja valdkond, Labor) |
| Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: kolmapäev, 5. veebruar 2025 17:17 Adressaat: Signe Leito Teema: Proposed addition of a new monograph to the work programme of Group 10A: Thalidomide: EDQM-2025-00602-mail
Please make sure to include in any reply our mail reference: EDQM-2025-00602-mail **************************************************************************** European Pharmacopoeia Commission Secretariat RZ/PH/ 2025-00590L Strasbourg, 5 February 2025 JSB/mk
FOR THE ATTENTION OF NPAs Copy: Presidium Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed addition of the monograph Thalidomide to the work programme of Group 10A.
In order to have access to the survey, please copy and paste this link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=173761&lang=en
Deadline for replies: 7 March 2025
With kind regards,
On behalf of Dr Jaume SANZ-BISET
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
Mireille KOPF Assistant - European Pharmacopoeia Department EDQM - Council of Europe 7 Allee Kastner Cs-30026 F-67081 Strasbourg France Tel. : +33 (0)3 88 41 28 53 [email protected] www.edqm.eu
**************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00602-mail